Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +11.7% | -3.5% | 2 / 3 | +170.7% | +5.98 pp | -10.01 pp | +16.9% | 0.09 | 4.58 | 144 | +170,7% | 30,1 | +82,9% | 4.58 | 6.37 | −28,1% |
| Pts | 0 | 0 | 8 | 12 | 12 | 0 | 4 | 12 | 12 | |||||||
Valuation annotation:Price: 10.000 (close price on 2026-10-19)EPS (TTM): 2.183
Financial charts
1.Revenue & growth
VND bn144Q2/26
1.Revenue & growth
VND bn144Q2/26
2.Profit & growth
VND bn27,9Q2/26
3.Profit mix (Penman)
VND bn109Q2/26
4.Margins & cost structure
%13.3%Q2/26
5.Returns & cash cycle
% · days2.3%Q2/26
6.Earnings quality & cash
VND bn57,5Q2/26
7.Asset structure
VND bn986Q2/26
8.Funding & debt health
VND bn · times986Q2/26
9.Revenue backlog
VND bn12,2Q2/26
10.Valuation
times · %6,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %576Q2/26
Adjusted EPS growth, latest quarter
19.7%
Average adjusted EPS growth, 3 quarters
-0.9%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
93.6%
Source: vnstockData through Q2/26